La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Paranovus Entertainment Technology Bilan de santé

Santé financière contrôle des critères 3/6

Paranovus Entertainment Technology possède un total de capitaux propres de $5.2M et une dette totale de $2.3M, ce qui porte son ratio d'endettement à 44.3%. Son actif total et son passif total sont $7.7M et de $2.6M.

Informations clés

44.3%

Ratio d'endettement

US$2.29m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	US$944.24k
Fonds propres	US$5.17m
Total du passif	US$2.56m
Total des actifs	US$7.73m

Mises à jour récentes de la santé financière

Recent updates

Take Care Before Jumping Onto Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) Even Though It's 26% Cheaper

Mar 20

Here's What To Make Of Happiness Biotech Group's (NASDAQ:HAPP) Returns On Capital

Jan 24

Happiness Biotech stock surge as its e-commerce business grew over 70% M/M in December

Jan 11

Happiness Biotech rallies on subsidiary receiving policy granting 80% tax rebates from local government

Dec 16

Would Shareholders Who Purchased Happiness Biotech Group's (NASDAQ:HAPP) Stock Year Be Happy With The Share price Today?

Nov 24

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de PAVS ( $2.9M ) dépassent ses passifs à court terme ( $2.6M ).

Passif à long terme: PAVS n'a pas de passif à long terme.

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de PAVS ( 26% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de PAVS est passé de 1.7% à 44.3% au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: PAVS dispose de moins d'un an de piste de trésorerie sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: PAVS dispose de moins d'un an de marge de trésorerie si le flux de trésorerie disponible continue de diminuer à un taux historique de 53.1 % chaque année

Paranovus Entertainment Technology Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Paranovus Entertainment Technology Ltd. announced delayed 20-F filing

Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Happiness Development Group Limited announced delayed 20-F filing

Happiness Development Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

Recent updates

Paranovus Entertainment Technology Ltd. announced delayed 20-F filing

New minor risk - Financial data availability

High number of new and inexperienced directors

High number of new and inexperienced directors

New major risk - Market cap size

Take Care Before Jumping Onto Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) Even Though It's 26% Cheaper

First half 2024 earnings released: EPS: US$2.06 (vs US$0.053 loss in 1H 2023)

Sentiment Still Eluding Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS)

Paranovus Entertainment Technology Ltd. (NasdaqCM:PAVS) entered into a non-binding letter of intent to acquire 100% of Blueline Studios Inc. from Caravan Digital L.P.

Paranovus Entertainment Technology Ltd. (NasdaqCM:PAVS) entered into a non-binding letter of intent to acquire 100% of Blueline Studios Inc. from Caravan Digital L.P.

Full year 2023 earnings released: US$253 loss per share (vs US$24.30 loss in FY 2022)

New major risk - Share price stability

Paranovus Entertainment Technology Ltd., Annual General Meeting, Jun 30, 2023

First half 2023 earnings released: US$9.57 loss per share (vs US$0.37 loss in 1H 2022)

An unknown buyer agreed to acquire 70% stake in Happy Automobile Service (Nanping) Co., Ltd. from Happy Automobile Service (Nanping) Co., Ltd. for CNY 1.4446 million.

Happiness Development Group Limited Announces Chief Financial Officer Changes

First half 2023 earnings released: US$9.57 loss per share (vs US$0.37 loss in 1H 2022)

Happiness Development Group Limited Announces Board Changes

Happiness Development Group Limited Announces Board and Committee Changes

High number of new directors

Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Happiness Development Group announces 1-for-20 reverse stock split

Happiness Development Group Limited announced delayed 20-F filing

Happiness Development Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

Less than half of directors are independent

Happiness Development Group Limited announced that it expects to receive $10 million in funding

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Investor sentiment improved over the past week

Happiness Biotech Launches Lucidum Tablets on Douyin Mall

Full year 2021 earnings released: EPS US$0.03 (vs US$0.53 in FY 2020)

Happiness Biotech Group (NASDAQ:HAPP) Could Be Struggling To Allocate Capital

Happiness Biotech inks EV distribution agreement with Geely's subsidiary

A Look At Happiness Biotech Group's (NASDAQ:HAPP) Share Price Returns

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: US$2.40

Happiness Biotech Group Limited Launches Auto Sales Platform "Happy Auto"

First half 2021 earnings released: EPS US$0.13

Here's What To Make Of Happiness Biotech Group's (NASDAQ:HAPP) Returns On Capital

Investor sentiment improved over the past week

New 90-day high: US$2.12

Happiness Biotech stock surge as its e-commerce business grew over 70% M/M in December

Happiness Biotech rallies on subsidiary receiving policy granting 80% tax rebates from local government

Would Shareholders Who Purchased Happiness Biotech Group's (NASDAQ:HAPP) Stock Year Be Happy With The Share price Today?

Happiness Biotech Group Limited Approves Appointment of Wenhui Lin as Director

Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores

New 90-day low: US$1.68

New 90-day low: US$1.93

New 90-day low - US$2.25

New 90-day low - US$2.35

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines